Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

RECOVAC Collaborators , Kho, M. M. L., Messchendorp, A. L., Frölke, S. C., Imhof, C., Koomen, V. J., Malahe, S. R. K., Vart, P., Geers, D., de Vries, R. D., GeurtsvanKessel, C. H., Baan, C. C., van der Molen, R. G., Diavatopoulos, D. A., Remmerswaal, E. B. M., van Baarle, D., van Binnendijk, R., den Hartog, G., de Vries, A. P. J., Gansevoort, R. T., & 4 othersBemelman, F. J., Reinders, M. E. J., Sanders, J-S. F. & Hilbrands, L. B., Mar-2023, In: Lancet Infectious Diseases. 23, 3, p. 307-319 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant

RECOVAC Collaborators , Sanders, J. S. F., Lianne Messchendorp, A., de Vries, R. D., Baan, C. C., van Baarle, D., van Binnendijk, R., Diavatopoulos, D. A., Geers, D., Schmitz, K. S., van Kessel, C. H. G., Hartog, G. D., Kho, M. M., Koopmans, M. P., van der Molen, R. G., Remmerswaal, E. B., Rots, N., Gansevoort, R. T., Bemelman, F. J., Hilbrands, L. B., & 1 othersReinders, M. E., 1-Feb-2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e188-e199 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy

RECOVAC Collaborators , Bouwmans, P., Messchendorp, A. L., Imhof, C., Sanders, J-S. F., Hilbrands, L. B., Reinders, M. E. J., Vart, P., Bemelman, F. J., Abrahams, A. C., van den Dorpel, R. M. A., Ten Dam, M. A. G. J., de Vries, A. P. J., Rispens, T., Steenhuis, M., Gansevoort, R. T. & Hemmelder, M. H., Mar-2023, In: Clinical Kidney Journal. 16, 3, p. 528-540 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Mycophenolic Acid Exposure Determines Antibody Formation Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study

RECOVAC Collaborators , Meziyerh, S., Bouwmans, P., van Gelder, T., van der Helm, D., Messchendorp, L., van der Boog, P. J. M., de Fijter, J. W., Moes, D. J. A. R. & de Vries, A. P. J., 14-Feb-2023, (E-pub ahead of print) In: Clinical Pharmacology and Therapeutics.

Research output: Contribution to journal › Article › Academic › peer-review

Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses

RECOVAC Consortium, den Hartog, Y., Malahe, S. R. K., Rietdijk, W. J. R., Dieterich, M., Gommers, L., Geers, D., Bogers, S., van Baarle, D., Diavatopoulos, D. A., Messchendorp, A. L., van der Molen, R. G., Remmerswaal, E. B. M., Bemelman, F. J., Gansevoort, R. T., Hilbrands, L. B., Sanders, J-S., GeurtsvanKessel, C. H., Kho, M. M. L., Reinders, M. E. J., & 2 othersde Vries, R. D. & Baan, C. C., 17-May-2023, In: npj Vaccines. 8, 10 p., 70.

Research output: Contribution to journal › Article › Academic › peer-review